COVER STORY


NeOnc Technologies Holdings – Developing Innovative Approaches to CNS Treatment


The field of medicine is in constant evolution, with scientific advancements turning challenges into possibilities. In the realm of brain and central nervous system (CNS) diseases, overcoming the Blood-Brain Barrier (BBB) has been one of the most significant hurdles. Despite progress in pharmaceuticals, effectively delivering therapeutics to the brain remains a complex challenge. NeOnc Technologies Holdings is addressing this head-on, developing innovative approaches to CNS treatment that have a goal  to improve patient outcomes. Founded in 2008, NeOnc Technologies Holdings was born from the vision to address the critical challenges of treating brain and CNS disorders, particularly brain cancers such as glioblastoma. The company has under development drug delivery technologies designed to navigate the BBB, potentially paving the way for more effective and targeted treatments. At B... Read more



LISTING   

Latest Magazine